Parkinsonism-Dementia Complex of Guam

Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders: Second Edition

Volumn , Issue , 2011, Pages 171-178

  Oyanagi, Kiyomitsu ^a,b   Hashimoto, Tomoyo ^a,c   Yamazaki, Mineo ^a,d  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO GAS CO LTD   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Guam; Neurofibrillary tangle; Parkinsonism dementia complex; Tau; TDP 43

Indexed keywords

EID: 84886015706     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444341256.ch18     Document Type: Chapter

References (69)

1. Hirano A, Kurland LT, Krooth RS et al. Parkinsonism-dementia complex, an endemic disease on Guam. I. Clinical features. Brain 1961; 84: 642-661.
2. Hirano A, Malamud N, Kurland LT. Parkinsonism-dementia complex, an endemic disease on Guam. Il Pathological features. Brain 1961; 84: 662-679.
3. Kurland LT, Mulder DW. Epidemiologic investigations of amyotrophic lateral sclerosis. Part 1. Preliminary report on geographic distribution, with special reference to the Mariana islands, including clinical and pathological observations. Neurology 1954; 4: 355-378, 438-448.
4. Malamud N, Hirano A, Kurland LT. Pathoanatomic changes in amyotrophic lateral sclerosis on Guam. Arch Neurol 1961; 5: 401-411.
5. Hirano A, Malamud N, Elizan TS et al. Amyotrophic lateral sclerosis and Parkinsonism-dementia complex on Guam. Further pathologic studies. Arch Neurol 1966; 15: 35-51.
6. Anderson FH, Richardson EP, Jr, Okazaki H et al. Neurofibrillary degeneration on Guam: frequency in Chamorros and non Chamorros with no known neurological disease. Brain 1979; 102: 65-77.
7. Oyanagi K, Makifuchi T, Ohtoh T et al. Amyotrophic lateral sclerosis of Guam: the nature of the neuropathological findings. Acta Neuropathol 1994; 88: 405-412.
8. Oyanagi K, Wada M. Neuropathology of parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam: an update. J Neurol 1999; 246 (Suppl 2): II/19-II/27.
9. Wada M, Uchihara T, Nakamura A et al. Bunina bodies in amyotrophic lateral sclerosis on Guam: a histochemical, immunohistochemical and ultrastructural investigation. Acta Neuropathol 1999; 98: 150-156.
10. Morris HR, Al-Sarraj S, Schwab C et al. A clinical and pathological study of motor neurone disease on Guam. Brain 2001; 124: 2215-2222.
11. Garruto RM, Yanagihara R, Gajdusek DC. Disappearance of highincidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Neurology 1985; 35: 193-198.
12. Plato CC, Garruto RM, Galasko D et al. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol 2003; 157: 149-157.
13. Yanagihara RT, Garruto RM, Gajdusek DC. Epidemiological surveillance of amyotrophic lateral sclerosis and parkinsonism-dementia in the commonwealth of the Northern Mariana Islands. Ann Neurol 1983; 13: 79-86.
14. Garruto RM, Gajdusek DC, Chen KM. Amyotrophic lateral sclerosis and parkinsonism-dementia among Filipino migrants to Guam. Ann Neurol 1981; 10: 341-350.
15. Plato CC, Garruto RM, Fox KM et al. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 25-year prospective case-control study. Am J Epidemiol 1986; 124: 643-656.
16. Plato CC, Galasko D, Garruto RM et al. ALS and PDC of Guam. Fortyyear follow-up. Neurology 2002; 58: 765-773.
17. Galasko D, Salmon DP, Craig UK et al. Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000. Neurology 2002; 58: 90-97.
18. Chen X, Xia Y, Gresham LS et al. ApoE and CYP2D6 polymorphism with and without parkinsonism-dementia complex in the people of Chamorro, Guam. Neurology 1996; 47: 779-784.
19. Buée L, Pérez-Tur J, Leveugle B et al. Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/parkinsonism-dementia complex: genotype analysis and relationship to neuropathological changes. Acta Neuropathol 1996; 91: 247-253.
20. Conrad C, Andreadis A, Trojanowski JQ et al. Genetic evidence for the involvement of t in progressive supranuclear palsy. Ann Neurol 1997; 41: 277-281.
21. Poorkaj P, Tsuang D, Wijsman E et al. TAU as a susceptibility gene for amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam. Arch Neurol 2001; 58: 1871-1878.
22. Sie W, Choi Y, Chapman NH et al. Identification of novel susceptibility loci of Guam neurodefenerative disease: challenges of genome scans in genetic isolates. Hum Mol Genet 2009; 18: 3725-3738.
23. Hermosura MC, Cui AM, Go RCV et al. Altered functional properties of a TRPM2 variant in Guamanian ALS and PD. Proc Natl Acad Sci 2008; 105: 18029-18034.
24. Hermosura MC, Nayakanti H, Dorovkov MV et al. A TRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two Guamanian neurodegenerative disorders. Proc Natl Acad Sci 2005; 102: 11510-11515.
25. Murakami N. Parkinsonism-dementia complex on Guam-overview of clinical aspects. J Neurol 1999; 246 (Suppl 2): II/16-II/18.
26. Chen KM, Chase TN. Parkinsonism-dementia. Handb Clin Neurol 1985; 49: 167-183.
27. Cambell RJ, Steele JC, Cox TA et al. Pathologic findings in the retinal pigment epitheliopathy associated with the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Ophthalmology 1993; 100: 37-42.
28. Doty RL, Perl DP, Steele JC et al. Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer's and idiopathic Parkinson's desease. Neurology 1991; 41: 77-80: discussion 80-81.
29. Low PA, Ahlskog JE, Petersen RC et al. Autonomic failure in Guamanian neurodegenerative disease. Neurology 1997; 49: 1031-1034.
30. Perl D. Amyotrophic lateral sclerosis-parkinsonism-dementia complex of Guam. In: Markesbery WR (ed) Neuropathology of Dementing Disorders. London: Arnold, 1998, pp. 269-292.
31. Hof PR, Pearl DP, Loerzel AJ et al. Neurofibrillary tangle distribution in the cerebral cortex of parkinsonism-dementia cases from Guam: differences with Alzheimer's disease. Brain Res 1991; 564: 306-313.
32. Hirano A, Dembitzer HM, Kurland LT et al. The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and "rod-like" structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism-dementia complex. J Neuropathol Exp Neurol 1968; 27: 167-182.
33. Schmidt ML, Lee VMY, Saido T et al. Amyloid plaques in Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex contain species of A ß similar to those found in the amyloid plaques of Alzheimer's disease and pathological aging. Acta Neuropathol 1998; 95: 117-122.
34. Mikossy J, Steele JC, Yu S et al. Enduring involvement of tau, beta-amyloid, a-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC). Acta Neuropathol 2008; 116: 625-637.
35. Wakayama I, Kihira T, Yoshida S et al. Rare neuropil threads in amyotrophic lateral sclerosis and parkinsonism-dementia on Guam and in the Kii Peninsula of Japan. Dementia 1993; 4: 75-80.
36. Joachim CL, Morris JH, Kosik KS et al. Tau antisera recognize neurofi-brillary tangles in a range of neurodegenerative disorders. Ann Neurol 1987; 22: 514-520.
37. Schwab C, Steele JC, McGeer PL. Dystrophic neurites are associated with early stage extracellular neurofibrillary tangles in the parkinsonism-dementia complex of Guam. Acta Neuropathol (Berl) 1997; 94: 486-492.
38. Oyanagi K, Makifuchi T, Ohtoh T et al. The neostriatum and nucleus accumbens in parkinsonism-dementia complex of Guam: a patho logical comparison with Alzheimer's disease and progressive spranuclear palsy. Acta Neuropathol 1994; 88: 122-128.
39. Nakano I, Hirano A. Neuron loss in the nucleus basalis of Meynert in parkinsonism-dementia complex of Guam. Ann Neurol 1983; 13: 87-91.
40. Yamazaki M, Arai Y, Baba M et al. a-synuclein inclusions in amygdala in the brains of patients with the parkinsonism-dementia complex of Guam. J Neuropathol Exp Neurol 2000; 59: 585-591.
41. Forman MS, Schmidt ML, Kasturi S et al. Tau and a-synuclein pathology in amygdala of parkinsonism-dementia complex patients of Guam. Am J Pathol 2002; 160: 1725-1731.
42. Goto S, Hirano A, Matsumoto S. Immunohistochemical study of the striatal efferents and nigral dopaminergic neurons in parkinsonism-dementia complex on Guam in comparison with those in Parkinson's and Alzheimer's diseases. Ann Neurol 1990; 27: 520-527.
43. Oyanagi K, Tsuchiya K, Yamazaki M et al. Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and parkinsonism-dementia complex of Guam: specific pathological features. J Neuropathol Exp Neurol 2001; 60: 393-402.
44. Oyanagi K, Makifuchi T, Ohtoh T et al. Distinct pathological features of the Gallyas-and tau-positive glia in the parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. J Neuropathol Exp Neurol 1997; 56: 308-316.
45. Yamazaki M, Hasegawa M, Mori O et al. Tau-positive fine granules in the cerebral white matter: a novel finding among tauopathies exclusive to parkinsonism-dementia complex of Guam. J Neuropathol Exp Neurol 2005; 64: 839-846.
46. Buée L, Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 1999; 9: 681-693.
47. Mawal-Dewan M, Schmidt ML, Balin B et al. Identification of phosphorylation sites in PHF-tau from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex. J Neuropathol Exp Neurol 1996; 55: 1051-1059.
48. Arai T, Hasegawa M, Akiyama H et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 602-611.
49. Cairns NJ, Bigio EH, Mackenzie IRA et al. Neuropathologic diagnostic and nosological criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 2007; 114: 5-22.
50. Neumann M, Sampathu DM, Kwong LK et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314 (5796): 130-133.
51. Seelaar H, Schelhaas HJ, Azmani A et al. TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations. Brain 2007; 130: 1375-1385.
52. Hasegawa M, Arai T, Akiyama H et al. TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 2007; 130: 1386-1394.
53. Geser F, Winton MJ, Kwong LK et al. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol 2008; 115: 133-145.
54. Maekawa S, Leigh PN, King A et al. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1mutations. Neuropathology 2009; 29: 672-683.
55. Mimuro M, Kokubo Y, Kuzuhara S. Similar topographic distribution of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonism-dementia complex in people living in the Kii peninsula of Japan suggests a single tauopathy. Acta Neuropathol 2007; 113: 653-658.
56. Kuzuhara S, Kokubo Y, Sasaki R et al. Familial amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Kii Peninsula of Japan: clinical and neuropathological study and tau analysis. Ann Neurol 2001; 49: 501-511.
57. Shiraki H, Yase Y. Amyotrophic lateral sclerosis and parkinsonism-dementia in the Kii Peninsula: comparison with the same disorders in Guam and with Alzheimer's disease. In: Vinken PJ, Bruyn GW, Klawans HL, Vianney de Jong JMB (eds) Handbook of Clinical Neurology, Vol. 59. Diseases of the Motor System. Amsterdam: Elsevier Science, 1991, pp. 273-300.
58. Kokubu Y, Kuzuhara S. Neurofibrillary tangles in ALS and parkinsonism-dementia complex focus in Kii, Japan. Neurology 2004; 63: 2399-2401.
59. Perl DP, Gajdusek DC, Garruto RM et al. Intraneuronal aluminium accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science 1982; 217: 1053-1055.
60. Gellein K, Garruto RM, Syversen T et al. Concentrations of Cd, Co, Cu, Fe, Mn, Rb, V, and Zn in formalin-fixed brain tissue in amyotrophic lateral sclerosis and Parkinsonism-dementia complex of Guam determined by high-resolution ICP-MS. Biol Trace Elem Res 2003; 96: 39-60.
61. Garruto RM, Yanagihara R, Gajdusek DC et al. Concentrations of hevy metals and essential minerals in garden soil and drinking water in the western Pacific. In: Chen KM, Yase Y (eds) Amyotrophic Lateral Scolerosis in Asia and Oceania. Taipei: National Taiwan University, 1984, pp. 265-330.
62. Yase Y. ALS in the Kii peninsula: one possible etiological hypothesis. In: Tsubaki T, Toyokura Y (eds) Amyotrophic Lateral Sclerosis. Tokyo: University of Tokyo Press, 1976, pp. 307-318.
63. Cox PA, Banack SA, Murch SJ. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc Natl Acad Sci 2003; 100: 13380-13383.
64. Borenstein AR, Mortimer JA, Schofield E et al. Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam. Neurology 2009; 68: 1764-1771.
65. Spencer PS, Nunn PB, Hugon J et al. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 1987; 237: 517-522.
66. Wilson JMB, Khabazian I, Wong MC et al. Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour. NeuroMol Med 2002; 1: 207-221.
67. Garruto RM, Shankar SK, Yanagihara R et al. Low-calcium, highaluminum diet-induced motor neuron pathology in cynomolgus monkeys. Acta Neuropathol 1989; 78: 210-219.
68. Kihira T, Yoshida S, Yase Y et al. Chronic low-Ca/Mg high-Al diet induces neuronal loss. Neuropathology 2002; 22: 171-179.
69. Oyanagi K, Kawakami E, Kikuchi-Horie K et al. Magnesium deficiency over generations in rats with special references to the pathogenesis of the parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Neuropathology 2006; 26: 115-128.